Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel Chimeric Poxvirus CF17 Improves Survival in a Murine Model of Intraperitoneal Ovarian Cancer Metastasis

Molecular Therapy — Oncolytics(2020)10.1016/j.omto.2020.10.002Source: DataRank Database

Novel Chimeric Poxvirus CF17 Improves Survival in a Murine Model of Intraperitoneal Ovarian Cancer Metastasis is a research paper published in Molecular Therapy — Oncolytics (2020). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.64)OA: goldTopics (25)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Yvonne R. Cornejo ORCID,Linda Flores,Caitlyn Hyde,Hoi Wa Ngai,Min Li ORCID

Live enrichment

PubMed:33251335 OpenAlex:https://openalex.org/W3092211482

National Institutes of Health

Grant: P30CA033572

National Cancer Institute

Grant: R43CA86768

National Cancer Institute

Grant: R01CA197359

National Cancer Institute

Grant: R44CA8678

National Institutes of Health

Grant: 5R44CA086768-03

HUMAN NEURAL STEM CELLS TARGET GENE THERAPY-BRAIN TUMORS

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

National Institutes of Health

Grant: 1R43CA086768-01

HUMAN NEURAL STEM CELLS TARGET GENE THERAPY-BRAIN TUMORS

National Institutes of Health

Grant: 5R01CA197359-02

Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy

FWCI

0.64

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.omto.2020.10.002

publisherhttps://doi.org/10.1016/j.omto.2020.10.002

publisherhttps://api.elsevier.com/content/article/PII:S2372770520301534?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2372770520301534?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33251335

Fields of Study

Virus-based gene therapy researchAnimal Virus Infections StudiesPlant Virus Research Studies03 medical and health sciences0302 clinical medicine

Keywords

Oncolytic virusOvarian cancerVirotherapyCancer researchVacciniaVirologyCancerMetastasisMedicineBiologyImmunologyVirusInternal medicineGeneRecombinant DNAchimeric poxvirusNeoplasms. Tumors. Oncology. Including cancer and carcinogensOriginal Articleoncolytic virotherapyRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being